http://www.xconomy.com/boston/2009/07/10/vertex-selling-telaprevir-payment-rights/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2009/07/10/vertex-selling-telaprevir-payment-rights/comment-page-1/#comment-70550 Vertex Deal Not the First for Morgan Stanley | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Mon, 13 Jul 2009 17:37:21 +0000 http://www.xconomy.com/?p=32825#comment-70550 [...] week, Vertex Pharmaceuticals (VRTX) announced that it would seek to sell the European rights to telaprevir, the company’s investigational HCV drug. The drug is currently partnered in Europe with [...] [...] week, Vertex Pharmaceuticals (VRTX) announced that it would seek to sell the European rights to telaprevir, the company’s investigational HCV drug. The drug is currently partnered in Europe with [...]

]]>